Company Profile VBI Vaccines Inc., a commercial stage biopharmaceutical company, develops vaccine candidates and novel technology platforms in Israel and internationally. It develops products based on eVLP, a platform for the design of enveloped virus-like particle vaccines; and Lipid Particle Vaccines platform, a proprietary formulation and process that allow vaccines and biologics to preserve stability, potency, and safety. The company's commercial stage product is Sci-B-Vac, a third-generation licensed hepatitis B vaccine for adults, children, and newborn infants. It is also involved in CMV vaccine program, which is in Phase I clinical trials for the prevention of cytomegalovirus infection; GBM immunotherapy program, a preclinical stage glioblastoma multiforme therapeutic vaccine candidate; and RSV vaccine program, a discovery stage novel respiratory syncytial virus vaccine candidate. The company was formerly known as SciVac Therapeutics Inc. and changed its name to VBI Vaccines Inc. in May 2016. The company is headquartered in Cambridge, Massachusetts. VBI Vaccines Inc. is a subsidiary of FDS Pharma ASS. MicroVision, Inc. 6244 185th Avenue NE Suite 100 Redmond, WA 98052 United States 425-936-6847 Sector: Technology Industry: Diversified Electronics Full Time Employees: 67 Statistics https://finance.yahoo.com/quote/MVIS/key-statistics?p=MVIS Holders https://finance.yahoo.com/quote/MVIS/holders?p=MVIS Mix News https://finance.yahoo.com/quote/MVIS?p=MVIS Home Page http://www.microvision.com
At close: March 3 $ 5.37 +0.69 (+14.74%) Day's Range 4.67 - 5.43 52 Week Range 1.99 - 5.43 Volume 427,151 Avg. Volume 116,654 Market Cap 211.8M Resist. 5.43 - 6.34 Sup. 4.36 Keep an eye on this IMO interesting stocks..... Friday tested the resistance ..closed few ticks under but above the VWAP VBI Vaccines, Inc. (VBIV) Gets European Support For Pivotal Phase III Sci-B-Vac Trial (Feb 15) http://www.insidermonkey.com/blog/v...for-pivotal-phase-iii-sci-b-vac-trial-552608/
There are two very strong buy signals on this graph, when the 20 day moving average (around $3.75) and the 50 day moving average (around $4.60) moved through the 200 day moving average.
VBIV closed 6.10 +0.73 (+13.59%) Day's Range 5.45 - 6.28 52 Week Range 1.99 - 6.28 Volume 959,177 Avg. Volume 116,295 Resistance: 6.28 - 7.34 today I was expecting, on my second scalps, to reach near 6.40 but it fell it did the 52 wk high ... will break that 6.28 to continue or a retrace will come up
On the chart alone the price has run too far ahead but if the fundamentals of the company have changed who will be brave enough to call the short term top? In hindsight there were some very good buying signals on this one.
VBIV yesterday hod to the day + 52 wk high to close at 5.64 -0.46 (-7.54%) Day's Range 5.52 - 6.46 52 Week Range1.99 - 6.46 Volume1,029,593 Avg. Volume 145,493
IMO the last ... with patience it could and will do new high JMHO... you DD today already tried to bounce some.... maybe shorter let it go 5.93+0.29 (+5.14%) Day's Range 5.65 - 6.05 52 Week Range 1.99 - 6.46 Volume 360,719 Avg. Volume 145,493 I don't know if anyone has noticed that the charts get automatically update daily ... whenever I can that is why I try to post the daily performance for info
nearly got some today but I was waiting where it close above or under 4.75/.80 ....now I see is above 5 I prefer to wait and see
